Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine transversus abdominis plane block for postoperative pain after laparoscopic gynecologic surgery
IRCT20190204042618N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of pain at 48 hours and Severity of nausea and vomiting at 48 hours. Started May 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190204042618N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190204042618N3.